Compulsory Licences Needed For Affordable Hepatitis C Innovative Drug Regimens 05/08/2014 by Intellectual Property Watch 1 Comment Compulsory licences should be issued to roll out generic versions of innovative HCV drugs. Only generic competition can push down the extortionate prices of these lifesaving medicines, while placing equitable access and public interest before monopolistic pharma companies’ business strategies, Daniele Dionisio argues.
Special Report: Update On Implementation Of The EU Patent Package 25/07/2014 by Maëli Astruc for Intellectual Property Watch Leave a Comment Significant progress has been made in the implementation of the European regulation to establish a European unitary patent and an international treaty which sets up a unified patent court. Given the loaded agenda for the coming year, it seems that a lot of work remains to be done. Meanwhile, an ongoing proceeding before the Court of Justice of the European Union (CJEU) initiated by Spain could bring down the whole system, according to sources.
Abundance Of Latin American Candidates For Senior WIPO Post 25/07/2014 by William New, Intellectual Property Watch Leave a Comment It has been said among some member states of the World Intellectual Property Organization that the next deputy director general responsible for development should come from the Latin American and Caribbean region. If that is the case, a look at some senior officials in Geneva from the region shows a significant pool of available talent from which to draw.
Trade, Innovation, Competition, IP In Two New Discussion Papers 24/07/2014 by Intellectual Property Watch Leave a Comment The International Centre for Trade and Sustainable Development recently issued papers on competition analyses of licensing agreements and on the measurement of trade and innovation.
New Medicines Patent Pool-Gilead Agreement For New HIV Drug In 112 Countries 24/07/2014 by Catherine Saez, Intellectual Property Watch Leave a Comment The Medicines Patent Pool today announced a new licensing agreement with Gilead Sciences for a new treatment still undergoing clinical trials. This agreement is expected to allow Chinese and Indian generic manufacturers to provide low-cost versions of the drug in 112 low-and middle-income countries.
Microsoft Online Portal Aims At Increased Innovation, IPR Use In Africa 22/07/2014 by Catherine Saez, Intellectual Property Watch Leave a Comment Microsoft, a strong advocate of intellectual property protection, has launched an online IP portal in Kenya with the aim of helping innovators better understand different means of protecting their software and reap the economic benefits of their innovations. The initiative is planned to spread to other African countries.
The Term ‘Indigenous Peoples’ Key For Identity, Rights, UN Experts Say 22/07/2014 by Intellectual Property Watch Leave a Comment United Nations experts are underlining the importance of using the term “indigenous peoples” in a UN draft set of sustainable development goals from which they say the term has been deleted.
India IP Policy Misrepresented By US Trade Representative, Indian Pharma Says 22/07/2014 by Catherine Saez, Intellectual Property Watch Leave a Comment An Indian pharmaceutical industry group has challenged the United States Trade Representative’s assessment of India’s intellectual property protection regime and suggested that India received more severe treatment than other countries solely on the basis of treatment of patented pharmaceuticals that it says is allowed under international rules.
EU-Funded Platform Connects SMEs, Researchers On Green Tech 21/07/2014 by Intellectual Property Watch Leave a Comment A European Union-funded initiative is seeking to strengthen the links between small and medium-sized enterprises (SMEs) and the research community on environmental technologies.
Report: Switzerland Again World’s Most Innovative; North-South Innovation Divide Remains 18/07/2014 by Catherine Saez, Intellectual Property Watch 2 Comments Is Europe the most innovative region in the world? In a well-regarded report, Switzerland has again been deemed the world’s most innovative nation, followed by the United Kingdom, Sweden, Finland and the Netherlands. But the annual Global Innovation Index also shows a persistent innovation divide between developed and developing countries, and this year focuses on the human factor in innovation.